Introduction 31
Athletes involved in contact sports such as Rugby Union are regularly exposed to 32 muscle damage during both training and match play (Naughton, Miller skinfolds. These groups are 1) gain muscle mass, 2) maintain current body 136 composition, 3) lose body fat). While 16 players were assigned to FO and 17 to P, 137 only 9 in FO and 11 in P completed the study. The mean age of participants was 22 138 years and 7 months (SD: 2 years 11 months; range: 18 years 11 months -27 years 11 139 months). Two participants dropped out of the study due to gastrointestinal illness and 140 7 to training related injury. Six players did not complete all data collection. procedure. Upper and lower body muscle soreness scores were rated using a diagram 235 of a person with muscle groups divided into six compartments for both sides of the 236 body (quadriceps, groin, calf, hamstrings, gluteus and upper body). Each muscle 237 group was rated from 1-5 with 1 being "very sore" and 5 being "feeling great". 238
Therefore the maximum score for the lower body was 50 and upper body was 10. All 239 questionnaires were completed prior to training. differences in variables between groups were assessed qualitatively as <1%, almost 265 certainly not; 1% to 5%, very unlikely; 5% to 25%, probably not; 25% to 75%, 266 possibly; 75% to 97.5%, likely; 97.5% to 99%, very likely; >99%, most likely. If the 267 chances of a variable having beneficial and harmful differences which were >5%, the 268 true effect was deemed to be unclear (Hopkins, 2010) . Quantitative data are presented 269 as percent beneficial/trivial/harmful. Data are provided as mean ± standard deviation 270 (SD) and standardized mean differences (SMD), unless otherwise stated. 271
272

Results
274
Training 275
The average weekly distance covered in the intensive metrics was FAST: FO 2.5±0.9 276 km, P 2.7±0.7 km; HMLD: FO 2.3±0.8 km P 2.5±0.7 km; SPRINT: FO 177±156 m P 277 166±170 m. There were small but unclear differences between FO and P for both 278 Twenty-seven percent of participants in P correctly stated that they were assigned to 295 the placebo, whereas a further 27% incorrectly believed they were assigned to the FO 296 condition and remaining participants were unsure. 297
Anthropometrics 299
In FO, body mass increased from 106.9±8.3 kg to 107.1±8.1 kg whereas in P, body 300 mass increased from 106.7±16.5 kg to 107.3±16.6kg (SMD -0.03, trivial; 100% most 301 likely trivial effect). In FO, the sum of eight skinfolds was 70.8±14.4 mm at baseline 302 and 67.5±15.5 mm post intervention, whereas P was 74.4±17.2 mm at baseline 303 decreasing to 71.5±17.6 mm post intervention. There was an unclear trivial effect on 304 the change in skinfolds from pre to post between FO and P (SMD: 0.02 trivial; 1/95/3 305 unclear). 306
307
Countermovement Jump 308
Peak force during the CMJ at baseline was 2705. 2). 317
318
Muscle soreness 319
Expressed as a change from baseline, with the exception of day 12, a likely or very 320 likely beneficial effect of FO on lower body muscle soreness was observed at all 321 timepoints (figure 3b). At baseline, median (IQR) upper body muscle soreness was 322 8(1.5) and 8(2) (maximum value 10 which equates to "no soreness") for FO and P 323 respectively. On Day 22 (two days after the in -house match), expressed as change 324 from baseline, there was a likely harmful effect of FO on upper body muscle soreness 325 whereby the muscle soreness was 4.57 out of a potential score of 10 (no muscle 326 soreness) for FO and 6.82 for P (Figure 3a) . Interestingly, the two players in FO that 327 recorded the maximum soreness at this time point were forwards and one player 328 played for the developmental squad against the senior squad for the match, so may 329 have been subjected to heavier impacts throughout the match. Repeating statistical 330 analysis of the upper body muscle soreness data set with this player's data at the 22 331 day timepoint removed reduced the SMD to -0.84 moderate (7/11/82 unclear). protein-based drink may attenuate muscle soreness by protecting the structural 390 integrity of the muscle cell from damage. We previously demonstrated that the 391 increase in plasma creatine kinase concentrations following eccentric exercise was 392 reduced with the addition of fish oil to a protein-based supplement (Philpott, 2018) . 393
These data indicate a reduced leakage of creatine kinase from the muscle cell into 394 circulation following fish oil ingestion. Hence, the exact mechanism for fish oil 395 ingestion reducing muscle soreness remains unclear. 396
The better CMJ performance scores with fish oil ingestion may also be due to a 398 reduced perception of muscle soreness. Alternatively, the benefit of fish oil ingestion 399 on CMJ performance may have been mediated at the neuromuscular level since 400 fatigue, other markers of wellness, stress, mood and sleep quality were only trivially 454 affected. However, no player reported a score lower than "normal" for stress or mood 455 and only one player rated sleep as lower than "normal" throughout the study. These 456 data suggest that although the training camp was intensive, it had little impact on 457 player mood, stress or sleep quality. Therefore, any potential impact of fish oil 458 ingestion on these measures could not be detected in this study. 459
460
Conclusion 461
The addition of fish oil (1546 mg of omega-3 PUFA; 551 mg EPA and 551 mg DHA) 462 to a protein-based drink for 5 weeks provided an effective strategy to reduce muscle 463 soreness and fatigue and better maintain CMJ performance during preseason training 464 in elite Rugby Union players. These beneficial effects may confer benefits to muscle 465 recovery between training sessions and also improve subsequent matchplay 466 performance, especially when the period between matches is short. 
